Abstract
A, Predicted probability (y-axis) of a patient developing late RB (top row) and late UI (second row) as derived from fixed-effects regression models for different treatment times (solar time of day, x-axis) and genotype for VAMP3 SNP rs11121022 and adjacent PER3 SNP rs172933, rs696305, rs35128310, rs488728, rs288640, and rs697689. Probabilities of developing each late side effect are given for patient groups grouped by genotype at each SNP. Possible patient genotypes are colored as follows: purple, homozygous for allele 1; green, heterozygous; yellow, homozygous for allele 2. Alleles are arbitrarily assigned as allele 1 or allele 2, and their assignments can be determined from B. Shaded areas show 95% CI for predictions. B, Proportion of patients in the study cohort (European population) with given genotypes for each SNP. Colors represent genotypes for homozygous alleles 1/1 (purple), heterozygotes (green), and homozygous allele 2 (yellow). Actual SNP alleles are provided in the text labels along with the expected proportion of patients with those genotypes according to population frequency estimates. C, Chromosome diagram showing the position of each SNP on chromosome 1 (GRCh38). The position of PER3 VNTR rs57875989 is shown in exon 18. Gene structures of VAMP3 and PER3 are shown beneath.